Drugs / HPV 16 E7:12-20
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00003895 | Apr 1999 → Sep 2013 | melanoma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HPV 16 E7:12-20 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003895 ↗ |
| Modality | Peptide | “HPV16E7:12-20 peptide vaccine” NCT00003895 ↗ |
| Route | Subcutaneous | “Given SC” NCT00003895 ↗ |